379 related articles for article (PubMed ID: 17011789)
1. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
2. [Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model].
Orth G
Bull Acad Natl Med; 2010 Jun; 194(6):923-40; discussion 941. PubMed ID: 21513129
[TBL] [Abstract][Full Text] [Related]
3. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.
Ramoz N; Rueda LA; Bouadjar B; Montoya LS; Orth G; Favre M
Nat Genet; 2002 Dec; 32(4):579-81. PubMed ID: 12426567
[TBL] [Abstract][Full Text] [Related]
4. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis.
Orth G
Curr Top Microbiol Immunol; 2008; 321():59-83. PubMed ID: 18727487
[TBL] [Abstract][Full Text] [Related]
5. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
Hohenstein E; Rady PL; Hergersberg M; Huber AR; Tyring SK; Bregenzer T; Streit M; Itin P
Dermatology; 2009; 218(2):114-8. PubMed ID: 19005244
[TBL] [Abstract][Full Text] [Related]
6. Homozygosity for the c.917A→T (p.N306l) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz.
Arnold AW; Burger B; Kump E; Rufle A; Tyring SK; Kempf W; Häusermann P; Itin PH
Dermatology; 2011 Feb; 222(1):81-6. PubMed ID: 21196704
[TBL] [Abstract][Full Text] [Related]
7. Epidermodysplasia verruciformis.
Burger B; Itin PH
Curr Probl Dermatol; 2014; 45():123-31. PubMed ID: 24643182
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses.
Lazarczyk M; Pons C; Mendoza JA; Cassonnet P; Jacob Y; Favre M
J Exp Med; 2008 Jan; 205(1):35-42. PubMed ID: 18158319
[TBL] [Abstract][Full Text] [Related]
9. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis.
Sun XK; Chen JF; Xu AE
Clin Exp Dermatol; 2005 Sep; 30(5):573-4. PubMed ID: 16045695
[TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.
Przybyszewska J; Zlotogorski A; Ramot Y
J Am Acad Dermatol; 2017 Jun; 76(6):1161-1175. PubMed ID: 28196644
[TBL] [Abstract][Full Text] [Related]
11. Acquired epidermodysplasia verruciformis.
Rogers HD; Macgregor JL; Nord KM; Tyring S; Rady P; Engler DE; Grossman ME
J Am Acad Dermatol; 2009 Feb; 60(2):315-20. PubMed ID: 19150275
[TBL] [Abstract][Full Text] [Related]
12. The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.
de Jong SJ; Créquer A; Matos I; Hum D; Gunasekharan V; Lorenzo L; Jabot-Hanin F; Imahorn E; Arias AA; Vahidnezhad H; Youssefian L; Markle JG; Patin E; D'Amico A; Wang CQF; Full F; Ensser A; Leisner TM; Parise LV; Bouaziz M; Maya NP; Cadena XR; Saka B; Saeidian AH; Aghazadeh N; Zeinali S; Itin P; Krueger JG; Laimins L; Abel L; Fuchs E; Uitto J; Franco JL; Burger B; Orth G; Jouanguy E; Casanova JL
J Exp Med; 2018 Sep; 215(9):2289-2310. PubMed ID: 30068544
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis].
Liang S; Zuo YG; Wang BX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):93-6. PubMed ID: 19317070
[TBL] [Abstract][Full Text] [Related]
14. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of local immunosurveillance.
Majewski S; Jablonska S
Am J Med Sci; 1992 Sep; 304(3):174-9. PubMed ID: 1335684
[TBL] [Abstract][Full Text] [Related]
15. Development of aggressive squamous cell carcinoma in epidermodysplasia verruciformis associated with human papillomavirus type 22b.
Kim T; Park JC; Roh MR; Park JM; Kim SH; Cho NH; Lee MG
Dermatology; 2010; 220(4):326-8. PubMed ID: 20460877
[TBL] [Abstract][Full Text] [Related]
16. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus.
Ramoz N; Rueda LA; Bouadjar B; Favre M; Orth G
J Invest Dermatol; 1999 Mar; 112(3):259-63. PubMed ID: 10084299
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population.
Pfister H; Fuchs PG; Majewski S; Jablonska S; Pniewska I; Malejczyk M
Arch Dermatol Res; 2003 Dec; 295(7):273-9. PubMed ID: 14618345
[TBL] [Abstract][Full Text] [Related]
18. A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome.
Kreuter A; Hochdorfer B; Brockmeyer NH; Altmeyer P; Pfister H; Wieland U;
Arch Dermatol; 2008 Mar; 144(3):366-72. PubMed ID: 18347293
[TBL] [Abstract][Full Text] [Related]
19. [Scattered papules in three Togolese children from a consanguineous marrige: epidermodysplasia verruciformis].
Saka B; Mouhari-Touré A; Kombaté K; Pitché P; Tchangaï-Walla K
Med Trop (Mars); 2009 Jun; 69(3):293-4. PubMed ID: 19702156
[TBL] [Abstract][Full Text] [Related]
20. The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.
Horton JS; Stokes AJ
Oncoimmunology; 2014 Jan; 3(1):e28288. PubMed ID: 24800179
[No Abstract] [Full Text] [Related]
[Next] [New Search]